Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series : World's leading Event Organizer
Recommended Conferences for maltodextrin nanoparticles
maltodextrin nanoparticles
As per available reports about 283 open access articles, 1123 conferences, 215 national symposiums are presently dedicated exclusively to maltodextrin nanoparticles and about 373 speakers gave presentations on maltodextrin nanoparticles.
Nanoparticles can be used to deliver antigens to immune cells, therefore increasing their immunogenicity. A better knowledge of their mechanisms of interaction with cells and the biological fluids is necessary to fully understand their potential as delivery systems of antigens. Most of nanotechnologies-antigens complex to formulate proteins implies surfactant, organic solvents, temperature conditions; all these parameters are generally considered to be deleterious from proteins and are limitations for further medical applications.
OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
o overcome these inconveniences, we developed a new concept based on porous nanoparticles to obtain protein loading in water without requiring any organic solvent or surfactant. These nanoparticles made from starch hydrolysate (maltodextrin) can be used alone or associated with lipids. Proteins loaded are efficiently protected from proteolysis and antigens are highly delivered within cells and when administered intra-nasally or sub-linguallly this delivery vehicle was capable of eliciting humoral, cellular and mucosal immunity without the use of adjuvant. This lecture will give an overview of the mechanisms implied using nanoparticles to deliver antigens to the immune cells using the nasal route of administration.
Relevant Conferences:
-
10th Vaccines & Vaccination Conference, June 16-18, 2016 Rome, Italy
-
13th Vaccines & Vaccination Conference, November 10-12, 2016 Melbourne, Australia
-
2nd Applied Microbiology Conference, October 31-November 02, 2016 Istanbul, Turkey
-
6th Cell & Stem Cells Research Conference, February 29-March 02, 2016 Philadelphia, USA
-
2nd Antibiotics Conference October 03-05, 2016 London, UK
-
5th Cancer Therapy Conference, September 28-30, 2015 Atlanta, Georgia, USA
-
Beneficial Microbes: Food, Pharma, Aqua & Beverages Industry Conference, September 23-25, 2016 Phoenix, USA
-
4th Bacteriology and Infectious Diseases Conference, May 16-18, 2016 San Antonio, USA
-
Allergy Conference, March 29-30, 2016 Valencia, Spain
-
4th Immunology Conference, September 28-30, 2015 Houston, Texas, USA
-
2nd Infectious Diseases Conference, August 25-27, 2016 Philadelphia, USA
-
2nd Influenza Conference, September 12-14, 2016 Berlin, Germany
-
Infection Prevention and Control Conference, Aug 1-2, 2016 Frankfurt, Germany
-
2nd Innate Immunity Conference, July 21-22, 2016 Berlin, Germany
-
2nd Parasitology Conference, August 01-03, 2016 Manchester, UK
-
2nd Antibodies Conference, July 14-15, 2016 Philadelphia, USA
-
2nd Neuroimmunology & Therapeutics Conference, March 31-April 02, 2016 Atlanta, USA
-
Influenza Vaccines for the World, 6-9 October 2015 Sao Rafael Atlantic Hotel, Albufeira, Algarve, Portugal
-
The 2015 Vaccine Summit, 13th - 15th October 2015 Cineworld: The O2, Peninsula Square, London
-
Conference on 3Rs Alternatives and Consistency Testing in Vaccine Lot Release Testing, 16 -18 September 2015 Hotel Zuiderduin, The Netherlands
-
Meningitis and Septicaemia in Children and Adults, 4th - 5th November 2015 Royal Society of Medicine, London, United Kingdom
-
Conference on 3Rs Alternatives and Consistency Testing in Vaccine Lot Release Testing, 16 -18 September 2015 Hotel Zuiderduin, The Netherlands
-
Meningitis and Septicaemia in Children and Adults, 4th - 5th November 2015 Royal Society of Medicine, London, United Kingdom
-
Meningitis and Septicaemia in Children and Adults, 4th - 5th November 2015 Royal Society of Medicine, London, United Kingdom
Relevant Societies:
-
Southern African HIV Clinicians Society
-
ANTIAIDS Foundation
-
AIDS Action Committee of Massachusetts
-
Infectious Diseases Society of America (IDSA)
-
American Society for Microbiology
-
Ecuadorian Society of Medical Technologists Laboratory (SOTEMELAB)
-
American Society for Microbiology
-
Médecins Sans Frontières
-
American Federation for Medical Research
Relevant Companies:
-
Metabolon, Inc.
-
Boston Biomedical
-
Zakłady Chemiczne Permedia S.A.
-
Astellas
-
Cipla
-
GlaxoSmithKline plc.
-
Merck & Co.
-
Novartis
-
Pfizer
-
Sunpharma
-
Vaxgen
This page will be updated regularly.
This page was last updated on April 26, 2024